+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Mesalamine API Global Market

Mesalamine API Global Market

Global Mesalamine API Market Industry Research Report 2026

Explore detailed insights, trends, growth drivers, key players, and forecasts for the Global Mesalamine API Market Industry Research Report 2026 market worldwide.

Pages: 210

Format: PDF

Date: 01-2026

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Mesalamine API Market Report (2026–2036)

Market Overview

Chem Reports projects that the Mesalamine API Market, valued at USD xxxx units in 2025, is expected to reach USD xxxx units by 2036, growing at a CAGR of xx% globally.

The Global Mesalamine API Market Report 2025 provides an extensive industry analysis of development drivers, market patterns, flows, and sizes. It calculates present and historical market values to forecast potential market performance during 2026–2036. This research integrates both primary and secondary data sources, examining government policies, market environment, competitive landscape, historical data, current trends, technological innovation, upcoming technologies, and technical progress in related industries.

Impact of COVID-19

Since the outbreak of COVID-19 in December 2019, the pandemic has spread worldwide, with the World Health Organization declaring it a public health emergency. The global impacts of COVID-19 significantly affected the Mesalamine API market in 2020, disrupting supply chains, altering demand patterns, and reshaping investment priorities across pharmaceutical manufacturing and gastrointestinal treatment sectors.

Market Segmentation

By Type

  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Mesalamine Tablets
  • Mesalamine Capsules
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Key players in the Mesalamine API market include:

  • Syntese A/S
  • Corden Pharma Bergamo
  • Ipca Laboratories
  • Divis Laboratories
  • Erregierre SpA
  • Cambrex Corporation
  • Ishita Active Pharma Ingredients
  • Lasa Laboratory
  • PharmaZell
  • CTX Lifescience
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Global Mesalamine API Market Intelligence Brief (2026–2036)

Short Description / Definition

Mesalamine (5-aminosalicylic acid) is an anti-inflammatory drug widely used in the treatment of ulcerative colitis and Crohn’s disease. As an active pharmaceutical ingredient (API), it is critical for oral formulations such as tablets and capsules. The market is shaped by gastrointestinal disease prevalence, regulatory compliance, and pharmaceutical innovation.

Regional Analysis

  • North America: Strong demand in gastrointestinal APIs, with the U.S. leading due to advanced pharmaceutical R&D and FDA oversight.
  • Europe: Growth driven by gastrointestinal drug development and generics. Germany, France, and the U.K. are key hubs, supported by EMA regulations.
  • Asia-Pacific: Fastest-growing region, led by China, India, and Japan. Expansion fueled by generic manufacturing, rising prevalence of IBD, and government healthcare initiatives.
  • South America: Moderate growth, with Brazil showing demand in gastrointestinal APIs and generics.
  • Middle East & Africa: Emerging adoption in gastrointestinal treatments, though market penetration remains limited compared to other regions.

Porter’s Five Forces

  1. Competitive Rivalry: High; global players (Ipca, Divis, Cambrex, PharmaZell) compete with regional manufacturers.
  2. Threat of New Entrants: Moderate; entry barriers include regulatory approvals, GMP compliance, and capital-intensive production.
  3. Bargaining Power of Suppliers: Moderate; raw material suppliers hold leverage due to limited sources of salicylic acid intermediates.
  4. Bargaining Power of Buyers: High; pharmaceutical companies and hospitals demand cost-effective, compliant APIs.
  5. Threat of Substitutes: Moderate; alternative gastrointestinal APIs exist but Mesalamine remains relevant due to its efficacy in ulcerative colitis.

SWOT Analysis

Strengths

  • Established use in gastrointestinal treatments.
  • Wide applicability in oral formulations.
  • Strong demand in inflammatory bowel disease therapeutics.

Weaknesses

  • High production and compliance costs.
  • Regulatory complexity across regions.

Opportunities

  • Rising prevalence of IBD globally.
  • Growth in Asia-Pacific generic manufacturing.
  • Development of advanced formulations (controlled-release Mesalamine).

Threats

  • Raw material price volatility.
  • Stringent regulatory hurdles.
  • Competition from alternative gastrointestinal APIs.

Trend Analysis

  • Increasing use in oral formulations for ulcerative colitis and Crohn’s disease.
  • Rising demand in generic formulations across Asia-Pacific.
  • Growth in controlled-release technologies for enhanced efficacy.
  • Expansion of pharmaceutical R&D in gastrointestinal therapeutics.

Drivers & Challenges

Drivers

  • Expanding gastrointestinal drug market.
  • Rising prevalence of ulcerative colitis and Crohn’s disease worldwide.
  • Technological advancements in API manufacturing.

Challenges

  • High R&D and compliance costs.
  • Regulatory restrictions on gastrointestinal APIs.
  • Supply chain disruptions for raw materials.

Value Chain Analysis

  • Raw Materials: Salicylic acid intermediates, solvents.
  • Manufacturing: API synthesis, purification, GMP compliance.
  • Distribution: Global distributors, pharmaceutical partnerships.
  • End-Use Industries: Gastrointestinal pharmaceuticals, hospitals, research institutions.
  • Regulatory Bodies: FDA, EMA, WHO shaping compliance requirements.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in R&D for controlled-release formulations and cost-efficient production methods.
  • Investors: Focus on Asia-Pacific generic gastrointestinal markets where growth potential is strongest.
  • Regulators: Support harmonized global standards for gastrointestinal APIs.
  • Pharma Companies: Collaborate with API suppliers to ensure compliance and cost efficiency.
  • Distributors: Expand presence in emerging markets with campaigns highlighting therapeutic relevance.

Explore more reports here-

https://chemreports.com/reports

 

1. Market Overview of Mesalamine API
    1.1 Mesalamine API Market Overview
        1.1.1 Mesalamine API Product Scope
        1.1.2 Market Status and Outlook
    1.2 Mesalamine API Market Size by Regions:
    1.3 Mesalamine API Historic Market Size by Regions
    1.4 Mesalamine API Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2025 Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Mesalamine API Sales Market by Type
    2.1 Global Mesalamine API Historic Market Size by Type
    2.2 Global Mesalamine API Forecasted Market Size by Type
    2.3 Purity ? 97 %
    2.4 Purity ? 98 %
    2.5 Purity ? 99 %
3. Covid-19 Impact Mesalamine API Sales Market by Application
    3.1 Global Mesalamine API Historic Market Size by Application
    3.2 Global Mesalamine API Forecasted Market Size by Application
    3.3 Mesalamine Tablets
    3.4 Mesalamine Capsules
    3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Mesalamine API Production Capacity Market Share by Manufacturers
    4.2 Global Mesalamine API Revenue Market Share by Manufacturers
    4.3 Global Mesalamine API Average Price by Manufacturers
5. Company Profiles and Key Figures in Mesalamine API Business
    5.1 Syntese A/S
        5.1.1 Syntese A/S Company Profile
        5.1.2 Syntese A/S Mesalamine API Product Specification
        5.1.3 Syntese A/S Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.2 Corden Pharma Bergamo
        5.2.1 Corden Pharma Bergamo Company Profile
        5.2.2 Corden Pharma Bergamo Mesalamine API Product Specification
        5.2.3 Corden Pharma Bergamo Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.3 Ipca Laboratories
        5.3.1 Ipca Laboratories Company Profile
        5.3.2 Ipca Laboratories Mesalamine API Product Specification
        5.3.3 Ipca Laboratories Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.4 Divis Laboratories
        5.4.1 Divis Laboratories Company Profile
        5.4.2 Divis Laboratories Mesalamine API Product Specification
        5.4.3 Divis Laboratories Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.5 Erregierre SpA
        5.5.1 Erregierre SpA Company Profile
        5.5.2 Erregierre SpA Mesalamine API Product Specification
        5.5.3 Erregierre SpA Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.6 Cambrex Corporation
        5.6.1 Cambrex Corporation Company Profile
        5.6.2 Cambrex Corporation Mesalamine API Product Specification
        5.6.3 Cambrex Corporation Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.7 Ishita Active Pharma Ingredients
        5.7.1 Ishita Active Pharma Ingredients Company Profile
        5.7.2 Ishita Active Pharma Ingredients Mesalamine API Product Specification
        5.7.3 Ishita Active Pharma Ingredients Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.8 Lasa Loboratory
        5.8.1 Lasa Loboratory Company Profile
        5.8.2 Lasa Loboratory Mesalamine API Product Specification
        5.8.3 Lasa Loboratory Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.9 PharmaZell
        5.9.1 PharmaZell Company Profile
        5.9.2 PharmaZell Mesalamine API Product Specification
        5.9.3 PharmaZell Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.10 CTX Lifescience
        5.10.1 CTX Lifescience Company Profile
        5.10.2 CTX Lifescience Mesalamine API Product Specification
        5.10.3 CTX Lifescience Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.11 YC Biotech (Jiangsu)
        5.11.1 YC Biotech (Jiangsu) Company Profile
        5.11.2 YC Biotech (Jiangsu) Mesalamine API Product Specification
        5.11.3 YC Biotech (Jiangsu) Mesalamine API Production Capacity, Revenue, Price and Gross Margin
    5.12 Xinxiang Tianfeng Fine Chemical
        5.12.1 Xinxiang Tianfeng Fine Chemical Company Profile
        5.12.2 Xinxiang Tianfeng Fine Chemical Mesalamine API Product Specification
        5.12.3 Xinxiang Tianfeng Fine Chemical Mesalamine API Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Mesalamine API Market Size
    6.2 North America Mesalamine API Key Players in North America
    6.3 North America Mesalamine API Market Size by Type
    6.4 North America Mesalamine API Market Size by Application
7. East Asia
    7.1 East Asia Mesalamine API Market Size
    7.2 East Asia Mesalamine API Key Players in North America
    7.3 East Asia Mesalamine API Market Size by Type
    7.4 East Asia Mesalamine API Market Size by Application
8. Europe
    8.1 Europe Mesalamine API Market Size
    8.2 Europe Mesalamine API Key Players in North America
    8.3 Europe Mesalamine API Market Size by Type
    8.4 Europe Mesalamine API Market Size by Application
9. South Asia
    9.1 South Asia Mesalamine API Market Size
    9.2 South Asia Mesalamine API Key Players in North America
    9.3 South Asia Mesalamine API Market Size by Type
    9.4 South Asia Mesalamine API Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Mesalamine API Market Size
    10.2 Southeast Asia Mesalamine API Key Players in North America
    10.3 Southeast Asia Mesalamine API Market Size by Type
    10.4 Southeast Asia Mesalamine API Market Size by Application
11. Middle East
    11.1 Middle East Mesalamine API Market Size
    11.2 Middle East Mesalamine API Key Players in North America
    11.3 Middle East Mesalamine API Market Size by Type
    11.4 Middle East Mesalamine API Market Size by Application
12. Africa
    12.1 Africa Mesalamine API Market Size
    12.2 Africa Mesalamine API Key Players in North America
    12.3 Africa Mesalamine API Market Size by Type
    12.4 Africa Mesalamine API Market Size by Application
13. Oceania
    13.1 Oceania Mesalamine API Market Size
    13.2 Oceania Mesalamine API Key Players in North America
    13.3 Oceania Mesalamine API Market Size by Type
    13.4 Oceania Mesalamine API Market Size by Application
14. South America
    14.1 South America Mesalamine API Market Size
    14.2 South America Mesalamine API Key Players in North America
    14.3 South America Mesalamine API Market Size by Type
    14.4 South America Mesalamine API Market Size by Application
15. Rest of the World
    15.1 Rest of the World Mesalamine API Market Size
    15.2 Rest of the World Mesalamine API Key Players in North America
    15.3 Rest of the World Mesalamine API Market Size by Type
    15.4 Rest of the World Mesalamine API Market Size by Application
16 Mesalamine API Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • Purity ≥ 97%
  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Mesalamine Tablets
  • Mesalamine Capsules
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Key players in the Mesalamine API market include:

  • Syntese A/S
  • Corden Pharma Bergamo
  • Ipca Laboratories
  • Divis Laboratories
  • Erregierre SpA
  • Cambrex Corporation
  • Ishita Active Pharma Ingredients
  • Lasa Laboratory
  • PharmaZell
  • CTX Lifescience
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.